IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.
Published May 1, 2024 · Recall initiated: March 4, 2024
Summary
FDA records medical device Class II recall Z-1603-2024, published May 1, 2024 and initiated March 4, 2024. Recalling firm: Ion Beam Applications S.A.; Status: Ongoing; Reported quantity: 8 units; Lot: PTS-10 versions, PTS-11 versions, and PTS-12 versions. UDI-DI: 05404013801138; Serial Numbers: SAT.123, SAT.126, SAT.133, SAT.140, SBF.105, SBF.113, SBF.128, SBF.135. All configurations. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a risk of mistreatment as irradiation is not prevented when some safety parameters are out of tolerance.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ion Beam Applications S.A.
- Distributor
- US Nationwide distribution in the states of AR, FL, LA, KS, MI, TX, VA.
- Lot
- PTS-10 versions, PTS-11 versions, and PTS-12 versions. UDI-DI: 05404013801138; Serial Numbers: SAT.123, SAT.126, SAT.133, SAT.140, SBF.105, SBF.113, SBF.128, SBF.135. All configurations.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Belgium
Related recalls
- FDAIBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PTS-10September 18, 2024
- FDAIBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment ofAugust 28, 2024
- FDAIBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment ofJune 12, 2024
- FDAAlinity m System, Part Number: 08N53-002May 1, 2024
- FDARedux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.May 1, 2024
- FDAProteus235- Proton Therapy System: to produce and deliver a proton beam for the treatment of patients withJune 8, 2022
Questions about this recall
Was IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions. recalled?
Yes. FDA published recall Z-1603-2024 on May 1, 2024. Reported hazard: There is a risk of mistreatment as irradiation is not prevented when some safety parameters are out of tolerance.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail